Cooper Companies | COO - Capital Ordinário

Preço das Ações
62.88
Mudança Diária
1.54 2.51%
Mensal
-12.06%
Anual
-22.50%
Q2 Previsão
63.04




Capital Ordinário Alterar Data
Abbott USD 1.74B 23.39B 2025-09
Align Technology USD 71.62M 133K 2026-03
AtriCure USD 49.7M 10K 2025-09
Avanos Medical USD 46.46M 39.46K 2025-12
Bausch Health Companies USD 373.46M 2.93M 2026-03
Baxter International USD 514.28M 168.72M 2025-12
Bayer EUR 982.42M 0 2025-12
Becton, Dickinson and Co. USD 284.91M 1.72M 2025-12
Boston Scientific USD 1.48B 2.66M 2025-12
Cooper Companies USD 195.1M 3.71M 2025-12
Dentsply International USD 199.5M 196.5M 2025-09
Dexcom USD 384.8M 5.2M 2025-12
Edwards Lifesciences USD 580.7M 0 2025-12
Globus Medical USD 135.06M 449K 2025-12
Haemonetics USD 46.83M 82K 2025-12
Inogen USD 23K 0 2023-12
Insulet USD 70.35M 1000 2025-12
Integra LifeSciences USD 77.89M 34K 2025-12
Intuitive Surgical USD 355.17M 674K 2026-03
J&J USD 2.41B 1.74M 2025-12
Medtronic USD 1.28B 1.38M 2025-12
Merit Medical Systems USD 59.42M 134K 2025-12
Novartis USD 1.91B 10.64M 2025-12
ResMed USD 145.97M 25K 2025-12
STAAR Surgical USD 49.4M 49K 2025-12
Steris USD 98.15M 344K 2025-12
Stryker USD 382.4M 93K 2025-12
Tandem Diabetes Care USD 68.29M 518K 2025-12
Teleflex USD 44.19M 1000 2025-12
Utah Medical Products USD 3.19M 3.15M 2025-12
Zimmer Biomet Holdings USD 195.5M 2.68M 2026-03